Cord Tissue
Stem Cell
Umbilical cord tissue MSCs are found in the Wharton’s jelly of the umbilical cord tissue. MSCs derived from umbilical cord tissue can differentiate into specific cell types, such as bone cells, cartilage cells, and fat cells. Umbilical cord collection can only be done at birth, offering a unique opportunity to collect these cells during the delivery of a newborn without any risk or pain to the mother or child.
Clinical research has shown that umbilical cord tissue MSCs hold great potential for future regenerative medicine, particularly for degenerative and inflammatory conditions that currently have limited treatment options. These cells represent a significant hope for addressing medical conditions requiring treatment and improving the quality of life for millions of patients.
The umbilical cord tissue is also significant because it contains cells called MSCs. While MSCs cannot replace cord blood for bone marrow transplants, they can be utilised in regenerative medicine, aesthetics, anti-aging, and in treating joint degeneration conditions such as osteoarthritis and tendon injuries. Numerous studies have focused on the application of MSCs in treating conditions like atopic dermatitis, autoimmune diseases, diabetes, hair loss, erectile dysfunction, burns, scars, and more. The advantage of MSCs is that their use is not restricted to the donor alone but can also benefit close family members. MSCs can be cultured immediately after birth in our laboratory or cultured later when needed from the cryopreserved umbilical cord.
